Skip to Main Content

The new CEO of Legend Biotech says the company has seen no indication that it is the target of a Chinese investigation that has resulted in the arrest of his predecessor as well as employees of its parent company.

In an interview with STAT, CEO Ying Huang acknowledged the authorities’ investigation — said to focus on potential violations of import and export regulations — is ongoing. But he said Legend has no reason to believe it is currently a target. Ying also noted that, although former CEO Frank Zhang has been arrested, neither he nor other employees of Legend’s parent company, Genscript, have been charged.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!